FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1938559619> ?p ?o ?g. }

• W1938559619 abstract "Malignant Pleural Mesothelioma (MPM) is an aggressive tumor arising from mesothelial cells lining the pleural cavities characterized by resistance to standard therapies. Most of the molecular steps responsible for pleural transformation remain unclear; however, several growth factor signaling cascades are known to be altered during MPM onset and progression. Transducers of these pathways, such as PIK3CA-mTOR-AKT, MAPK, and ezrin/radixin/moesin (ERM) could therefore be exploited as possible targets for pharmacological intervention. This study aimed to identify ‘druggable’ pathways in MPM and to formulate a targeted approach based on the use of commercially available molecules, such as the multikinase inhibitor sorafenib and the mTOR inhibitor everolimus. We planned a triple approach based on: i) analysis of immunophenotypes and mutational profiles in a cohort of thoracoscopic MPM samples, ii) in vitro pharmacological assays, ii) in vivo therapeutic approaches on MPM xenografts. No mutations were found in ‘hot spot’ regions of the mTOR upstream genes (e.g. EGFR, KRAS and PIK3CA). Phosphorylated mTOR and ERM were specifically overexpressed in the analyzed MPM samples. Sorafenib and everolimus combination was effective in mTOR and ERM blockade; exerted synergistic effects on the inhibition of MPM cell proliferation; triggered ROS production and consequent AMPK-p38 mediated-apoptosis. The antitumor activity was displayed when orally administered to MPM-bearing NOD/SCID mice. ERM and mTOR pathways are activated in MPM and ‘druggable’ by a combination of sorafenib and everolimus. Combination therapy is a promising therapeutic strategy against MPM." @default.
• W1938559619 created "2016-06-24" @default.
• W1938559619 creator A5009087591 @default.
• W1938559619 creator A5027747604 @default.
• W1938559619 creator A5035613017 @default.
• W1938559619 creator A5039038744 @default.
• W1938559619 creator A5039473137 @default.
• W1938559619 creator A5041240875 @default.
• W1938559619 creator A5045318208 @default.
• W1938559619 creator A5050031420 @default.
• W1938559619 creator A5050080276 @default.
• W1938559619 creator A5052120219 @default.
• W1938559619 creator A5056702454 @default.
• W1938559619 creator A5058094535 @default.
• W1938559619 creator A5070751028 @default.
• W1938559619 creator A5072883486 @default.
• W1938559619 creator A5079227239 @default.
• W1938559619 creator A5086215437 @default.
• W1938559619 creator A5086229991 @default.
• W1938559619 creator A5087651693 @default.
• W1938559619 creator A5088354570 @default.
• W1938559619 date "2015-05-08" @default.
• W1938559619 modified "2023-10-01" @default.
• W1938559619 title "The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma" @default.
• W1938559619 cites W1941646742 @default.
• W1938559619 cites W1965885099 @default.
• W1938559619 cites W1967505269 @default.
• W1938559619 cites W1972043534 @default.
• W1938559619 cites W1980383541 @default.
• W1938559619 cites W1980807804 @default.
• W1938559619 cites W2002121944 @default.
• W1938559619 cites W2005252392 @default.
• W1938559619 cites W2007534790 @default.
• W1938559619 cites W2014400702 @default.
• W1938559619 cites W2017018900 @default.
• W1938559619 cites W2023412257 @default.
• W1938559619 cites W2023430483 @default.
• W1938559619 cites W2030644273 @default.
• W1938559619 cites W2039753580 @default.
• W1938559619 cites W2042015318 @default.
• W1938559619 cites W2042724367 @default.
• W1938559619 cites W2048477728 @default.
• W1938559619 cites W2058808716 @default.
• W1938559619 cites W2064074167 @default.
• W1938559619 cites W2079681700 @default.
• W1938559619 cites W2086557921 @default.
• W1938559619 cites W2089881887 @default.
• W1938559619 cites W2101650407 @default.
• W1938559619 cites W2111622605 @default.
• W1938559619 cites W2113954569 @default.
• W1938559619 cites W2131561057 @default.
• W1938559619 cites W2149218373 @default.
• W1938559619 cites W2161377790 @default.
• W1938559619 cites W2162577349 @default.
• W1938559619 cites W2172249877 @default.
• W1938559619 doi "https://doi.org/10.1186/s12885-015-1363-1" @default.
• W1938559619 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4429519" @default.
• W1938559619 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25952930" @default.
• W1938559619 hasPublicationYear "2015" @default.
• W1938559619 type Work @default.
• W1938559619 sameAs 1938559619 @default.
• W1938559619 citedByCount "24" @default.
• W1938559619 countsByYear W19385596192015 @default.
• W1938559619 countsByYear W19385596192016 @default.
• W1938559619 countsByYear W19385596192017 @default.
• W1938559619 countsByYear W19385596192018 @default.
• W1938559619 countsByYear W19385596192019 @default.
• W1938559619 countsByYear W19385596192020 @default.
• W1938559619 countsByYear W19385596192021 @default.
• W1938559619 countsByYear W19385596192023 @default.
• W1938559619 crossrefType "journal-article" @default.
• W1938559619 hasAuthorship W1938559619A5009087591 @default.
• W1938559619 hasAuthorship W1938559619A5027747604 @default.
• W1938559619 hasAuthorship W1938559619A5035613017 @default.
• W1938559619 hasAuthorship W1938559619A5039038744 @default.
• W1938559619 hasAuthorship W1938559619A5039473137 @default.
• W1938559619 hasAuthorship W1938559619A5041240875 @default.
• W1938559619 hasAuthorship W1938559619A5045318208 @default.
• W1938559619 hasAuthorship W1938559619A5050031420 @default.
• W1938559619 hasAuthorship W1938559619A5050080276 @default.
• W1938559619 hasAuthorship W1938559619A5052120219 @default.
• W1938559619 hasAuthorship W1938559619A5056702454 @default.
• W1938559619 hasAuthorship W1938559619A5058094535 @default.
• W1938559619 hasAuthorship W1938559619A5070751028 @default.
• W1938559619 hasAuthorship W1938559619A5072883486 @default.
• W1938559619 hasAuthorship W1938559619A5079227239 @default.
• W1938559619 hasAuthorship W1938559619A5086215437 @default.
• W1938559619 hasAuthorship W1938559619A5086229991 @default.
• W1938559619 hasAuthorship W1938559619A5087651693 @default.
• W1938559619 hasAuthorship W1938559619A5088354570 @default.
• W1938559619 hasBestOaLocation W19385596191 @default.
• W1938559619 hasConcept C104317684 @default.
• W1938559619 hasConcept C10679952 @default.
• W1938559619 hasConcept C121608353 @default.
• W1938559619 hasConcept C126322002 @default.
• W1938559619 hasConcept C142669718 @default.
• W1938559619 hasConcept C142724271 @default.
• W1938559619 hasConcept C143998085 @default.
• W1938559619 hasConcept C1491633281 @default.
• W1938559619 hasConcept C190283241 @default.

• next